Veristat has announced its intended acquisition of Certara's Regulatory and Medical Writing business, a move that will add ...
MedPage Today on MSN
FDA Says First 'Real-Time' Clinical Trial Is Underway
Two sponsors are on board, with a larger pilot program planned later this year ...
SALT LAKE CITY - Palladyne AI (NASDAQ:PDYN) announced today the issuance of U.S. Patent 12,517,525 B1 for its Bayesian Program Learning framework, marking the company’s second patent in four months.
Palladyne AI (NASDAQ: PDYN), a U.S.-based defense and industrial technology company commercializing embedded AI, collaborative autonomy, and advanced avionics for defense markets, today announced the ...
Second Patent in Four Months Strengthens IP Protection Across Autonomous Robotics, Multi-Sensor Surveillance, and Intelligent Edge Computing Markets SALT LAKE CITY--(BUSINESS WIRE)--Palladyne AI ...
Advances in artificial intelligence promise to help chemical engineers discover complex new materials. These materials could ...
West Point cadets have developed and tested software to train military leaders in making ethical decisions when using lethal autonomous weapons systems. The 'TEELAWS' program uses a Bayesian Ethical ...
Class of 2026 Cadets Boston Graf, Maksymilian Olszowka and Elizabeth “Ezra” Bardales labored on a capstone project, a ...
InsightRX today announced the launch of Apollo Studio, a new interface within its Apollo platform that enables pharmacy teams ...
Faces of 4D is a series from Student Affairs that explores the diverse and complex ways in which the DU community lives the ...
The Duke basketball program, after a pretty quiet first week and a half of the NCAA Transfer Portal cycle, has heard some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results